Inactive Instrument

Cangene Corporation Stock

CNJ

CA13758B1022

News in other languages: Cangene Corporation

13-02-20	IPSEN : et Inspiration finalisent la vente d'IB1001 à Cangene Corporation
13-02-06	IPSEN : cède les droits mondiaux de l'IB1001 à Cangene

More news

Emergent BioSolutions Canada Inc is a Canada-based biopharmaceutical company in the business of developing, manufacturing, and commercializing products and technologies for global markets. It operates in two segments: biopharmaceutical operations and contract services. The biopharmaceutical operations segment consist of sales of approved products and non- specialty plasma. The contract-services segment consists of third-party contract-manufacturing revenues at the Company's Winnipeg facilities, as well as at Cangene bioPharma in Baltimore. It also provides commercial contract-manufacturing services, primarily through a United States-based subsidiary. The Company's products include Rho(D) Immune Globulin (Human) for Injection (WinRho) SDF, Hepatitis B Immune Globulin (Human) Injection (HepaGam B) and Varicella Zoster Immune Globulin (Human) (VariZIG).

Employees

Sector

Pharmaceuticals

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!

13-12-13	Cangene Corporation : 12/13/2013 Cangene Reports First Quarter 2014 Results and Election of Directors	PU
13-12-11	Cangene Corporation : 12/11/2013 Cangene To Be Acquired By Emergent BioSolutions For US$222 Million	PU
13-07-29	Cangene Corporation : FDA lifts clinical hold on Cangene's hemophilia compound IB1001	PU
13-06-05	Cangene Corporation : Cangene Reports Third Quarter 2013 Results	PU
12-04-11	Cangene Corp : Further Senior Management Change at Cangene	PU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CANGENE CORPORATION	-.--%	+1.69%	-	-	0
REGENERON PHARMACEUTICALS, INC.	+0.06%	-4.09%	+34.70%	-5.93%	77.3B
CSL LIMITED	+1.32%	+4.27%	-12.10%	-33.47%	59.52B
MODERNA, INC.	+1.29%	+7.38%	+486.23%	+27.08%	57.4B
SAMSUNG BIOLOGICS CO.,LTD.	-0.21%	-2.96%	-11.54%	+25.36%	47.91B
UCB	-1.81%	+0.73%	+1.08%	+144.77%	46.2B
BIOGEN INC.	-0.07%	+2.51%	+50.34%	-15.22%	31.94B
INCYTE CORPORATION	+2.47%	-1.00%	+48.69%	+99.44%	24.68B
INNOVENT BIOLOGICS, INC.	+1.01%	+0.21%	-2.02%	+137.26%	21.08B
SWEDISH ORPHAN BIOVITRUM AB	-0.05%	-0.86%	+57.38%	+95.99%	15.65B
Average	+0.14%	-0.13%	+72.53%	+52.81%	42.41B
Weighted average by Cap.	+0.03%	-0.01%	+86.54%	+35.03%

Cangene Corporation Stock

Stocks

CNJ

CA13758B1022

Pharmaceuticals

Press Releases: Cangene Corporation

News in other languages: Cangene Corporation

Biopharmaceuticals

Company Profile